bởi Dynaccurate S.à r.l.

Management of dm+d mappings to the NHS regulation DAPB 4013


DyPharm was created in response to the NHS regulation DAPB 4013 which is intended to ensure that NHS patients have a precise record of their medications without any variation between different care sites.

It has been estimated that more than 200 million medication errors occur in the NHS every year, with adverse drug reactions linked to over 700 deaths, but possibly contributing as much as 22,000 deaths. In addition to fatalities, costs are estimated to be over £100 million.

The solution? Better linking of data... DyPharm was developed for exactly this purpose. The application will match, map and manage the links between older drug names and official names in the dm+d database.

With DyPharm hospitals and other prescribers can remain compliant with DAPB 4013 forever, reducing the risk of prescription errors and standardising naming conventions, including new drug names as dm+d updates. Our technology allows end-users to:

  • Automatically propose matches between legacy drug names with official dm+d unique identifiers

  • Incorporate 'many-to-one' links, for example duplicate drug names split across different applications but referring to a single drug

  • Maintain accepted mappings. Even when dm+d updates into the future, DyPharm will flag changes

  • Automatically share master drug lists with mappings at the touch of a button

Xem nhanh